My prediction for the next yearThe deal is suppose to close in 2024. However the different regulatory approvals and the recent experience of AQN suggests approval will likely take all of next year and perhaps into Q1 of 2025.
The prospect of increased debt, the cost of paying $30 million a month for new shares (with no revenue until closing), the additional legal cost of getting this deal to the finish line and the cost of integrating the new companies after reaching the finish line suggests the share price will perform poorly. I would expect the trading range to initially rise and then fall back between $39 and $41. The reason I see this weakness is too many questions, concerns and overhang while we wait out 12 months for regulatory approval. Its gonna take time for the share price to recover. (It never did from the last big deal they closed a few years ago).